Report of foreign issuer [Rules 13a-16 and 15d-16]

Consolidated Statements of Operations and Comprehensive Loss

v3.26.1
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Revenues    
Total net sales $ 132,697 $ 136,046
Cost of revenues    
Total cost of sales 77,336 75,807
Gross profit 55,361 60,239
Operating expenses    
Research and development, net 19,151 18,792
Selling, general and administrative 62,742 53,851
Total operating expenses 81,893 72,643
Operating loss (26,532) (12,404)
Financial income (expenses), net 2,732 1,473
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest, Total (23,800) (10,931)
Income tax benefit (expenses) 25 455
Share in net profits (losses) of associated companies 0 1,668
Net loss $ (23,825) $ (13,054)
Earnings Per Share, Basic $ (0.28) $ (0.18)
Weighted average shares outstanding - diluted 86,357 71,967
Comprehensive Loss    
Net loss attributable to non-controlling interests $ (23,825) $ (13,054)
Other comprehensive income (loss), net of tax:    
Foreign currency translation adjustments (1,323) 1,726
Unrealized gains (losses) on derivatives designated as cash flow hedges, net 2,569 (3,035)
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 1,246 (1,309)
Comprehensive loss attributable to Stratasys Ltd. (22,579) (14,363)
Products    
Revenues    
Total net sales 88,754 93,795
Cost of revenues    
Total cost of sales 46,554 47,268
Service [Member]    
Revenues    
Total net sales 43,943 42,251
Cost of revenues    
Total cost of sales $ 30,782 $ 28,539